Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 29 for “"RADIOIMMUNOCONJUGATES"”.
-
Exploiting the Heavy Chain Glycans for the Improvement of Radioimmunoconjugates
… the pharmacokinetic profiles of 89Zr-labeled radioimmunoconjugates. Fc receptors (FcR) are responsible for many of the interactions between immunoglobulins (IgG) and immune cells. In biomedicine, this interplay is critical to the activity of several types of immunotherapeutics; however, …
-
Bispecific Radioimmunoconjugates for Molecular Imaging and Radioimmunotherapy of HER2 Overexpressing Breast Cancer
… therapies. The hypothesis was that bispecific radioimmunoconjugates (bsRICs) developed against HER2 and another member of the HER receptor family would be able to successfully target cells expressing one or more receptor for molecular imaging and radioimmunotherapy of BC. Trastuzumab Fab …
-
Bifunctional chelators containing dibromomaleimides for the preparation of radioimmunoconjugates for PET imaging
… with metallic radioisotopes, to produce radioimmunoconjugates capable of imaging disease, predicting patient response to therapy, and informing pharmacokinetics of antibody biodistribution. Non-site-specific bioconjugations are simple and reliable but generate heterogeneous conjugates …
-
Trastuzumab Metal Chelating Polymer (MCP) Radioimmunoconjugates for Auger Electron Radioimmunotherapy of Breast Cancer
Objective: Trastuzumab modified with nuclear translocation sequence (NLS) peptides and diethylenetriaminepentaacetic acid (DTPA) for complexing 111In (111In-DTPA-NLS-trastuzumab) has shown promise for Auger electron radioimmunotherapy of HER2-positive breast cancer (BC), but a limitation is the low …
-
Intracellular delivery of radioimmunoconjugates that target the cancer testis antigen, NY-ESO-1
… liver lung. The aim of this study was to develop radioimmunoconjugates (RIC) to target NY-ESO-1 protein in cancer cells. Anti-NY-ESO-1 antibodies were modified by addition of DTPA for 111In-labelling or, in the presence of Iodogen, were 123I-labelled. Delivery of radiolabeled immunoconjugates …
-
The Development of Novel Radioimmunoconjugates for the PET Imaging and Radioimmunotherapy of Cancer
Antibodies have long played a vital role in nuclear medicine for both the diagnosis and therapy of various malignancies. The role and development of antibodies in nuclear medicine can be broadly separated into three different categories: 1) bioconjugation strategies, 2) immunoPET imaging, and 3) …
-
Internalising radioimmunoconjugates to target KRas cancer cells for simultaneous radio-ligand therapy and radiosensitisation
<p>The intracellular environment hosts many cancer-relevant proteins. Among them, Ras plays an important role and is frequently activated in cancers of unmet need, such as pancreatic ductal adenocarcinoma (PDAC), non-small cell lung cancers (NSCLC) and colorectal carcinoma (CRC). Despite years of …
-
Positron Emission Tomography (PET) of Breast Cancer Heterogeneous for HER2 and EGFR using Bispecific Radioimmunoconjugates
… The hypothesis was that novel bispecific radioimmunoconjugates (bsRICs) are capable of permit molecular imaging of both EGFR and HER2 receptors simultaneously with positron emission tomography (PET) and deliver more radioactivity to the tumor especially in the presence of receptor …
-
EGFR and HER2-targeted radioimmunoconjugates for theranostic molecular imaging and Auger electron radioimmunotherapy of breast cancer
Overexpression of the human epidermal growth receptor 1 (HER1, EGFR) and 2 (HER2) are common in breast cancer (BC) and confer a poor prognosis. HER2-targeted pertuzumab Fab fragments were modified with hexahistidine peptides for radiolabelling with 99mTc and EGFR-targeted panitumumab with DOTA …
-
HER2-targeted Theranostic Radioimmunoconjugates for SPECT Imaging and α-particle Radioimmunotherapy of HER2-positive Breast Cancer
… results suggest that theranostic HER2-targeting radioimmunoconjugates for SPECT imaging and α-particle RIT are promising for detection and treatment of HER-positive BC.
-
In vitro development of MUC1-CE Radioimmunotherapy for pancreatic ductal adenocarcinoma
… (RIT) uses radiolabelled antibodies, known as radioimmunoconjugates, to deliver cytotoxic doses of radiation directly to cancer cells. RIT may be beneficial in treating aggressive malignancies like pancreatic cancer (PC). This thesis explores the development and in vitro characterisation of two …
-
Using radioimmunoconjugates to target quiescent tumour cells via cancer stem cell and hypoxia-induced markers : an approach against metastatic disease and therapeutic resistance
… this thesis aims to describe work developing radioimmunoconjugates to target certain cancer stem cell and hypoxia-induced markers, specifically CD96 and carbonic anhydrase IX (CAIX), in efforts to potentially identify and eradicate dormant tumour cells, adding to the clinical arsenal against …
-
Radiotheranostics for Gynecological Pathologies
… the last several decades. The development of radioimmunoconjugates for use in immunoPET has not only allowed for the sensitive, specific, and high-resolution detection of disease, but has also enabled a deeper understanding of the disease biology, ultimately guiding more personalized …
-
Metal-chelating Polymers for Auger Electron Radioimmunotherapy
… of metal-chelating polymers (MCPs) into radioimmunoconjugates (RICs) can increase the specific activities of RICs due to the multiple radioactive isotope binding sites provided by MCPs. This thesis describes the synthesis and characterization of a library of biotin end-capped MCPs …
-
Expanding the Toolbox: Exploring the Lewis Acid Assisted 19F/18F-Isotopic Exchange Radiochemistry of BODIPY Dyes, and DiPODS: Development of a Novel Bioconjugation Reagent.
… Price lab research efforts sought to develop radioimmunoconjugates that operate through two phenyloxadiazolyl methyl sulfone (DiPODS) functionality to form irreversible bonds with antibody cysteine pairs. My contribution was to assist in synthesizing several of the multistep synthesis products …
-
Second Generation Phenyloxadiazolyl Methyl Sulfones for Thiol-Specific Bioconjugations
… strategies for the generation of immuno- and radioimmunoconjugates with improved immunoreactivity. The fifth and final chapter describe the preparation of antibody-based gold(I)-compounds with significant cytotoxicity in HER2-positive breast cancer cells.
-
Radioimmunotherapy of Metastatic Disease - Studies of Alpha- and Beta-particle-Emitting Radionuclides in a Preclinical Model
… or 211At-mAbs. The intratumoral distribution of radioimmunoconjugates was examined over time using digital autoradiography and was related to tumor histology. The results show that the tumor response was dose dependent after treatment with 177Lu-mAbs alone. Both evaluated activities of 211At-mAbs …
-
Development of Metal Chelators and Metal Chelating Polymers for Mass Cytometry and Positron Emission Tomography
… to antibodies can be radiolabeled to form radioimmunoconjugates (RICs). RICs labeled with radioactive 89Zr can act as imaging probes for a medical imaging technique called positron emission tomography (PET). A new chelator is needed to improve the in vivo stability of the 89Zr-chelator …
-
Lysine-lysine‒based enzymatically cleavable linkers for antibody-drug conjugates
… PEG4-LysLys analog. AR20.5-linker-DFO-[89Zr]Zr radioimmunoconjugates were prepared as large size models to mimic the in vitro and in vivo ADC behavior using positron emission tomography (PET) and other radioanalytical techniques (Chapter 4). In vivo evaluation of radioimmunoconjugates enabled …
-
Molecular imaging of mesothelin expressing cancers
… In vivo evaluation of these ⁹⁹mTc labelled radioimmunoconjugates in mesothelin expressing NCI-H226 tumour model, revealed low mesothelin specific tumour uptake. These findings were attributed to low expression of mesothelin on NCI-H226 cells as well as to the low affinity of mAbK1. An …
Page 1 of 2